ImpactRx Releases Key Data on U.S. Pharmaceutical Promotion Activity; - Keynote Presentation From Joint Conference with Prudential Financial Now Accessible on impactrx.com -.
MOUNT LAUREL Laurel, cities, United States
1 Town (1990 pop. 19,438), Prince Georges co., central Md., about halfway between Washington, D.C., and Baltimore; patented in the late 1600s, inc. 1870. , N.J., July 7 /PRNewswire/ -- ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the prescribing behavior of the nation's highest prescribing physicians, today announced that the keynote presentation from the Prudential Financial/ImpactRx joint conference on "Drug Launches and The Impact of Pharmaceutical Promotion on Physician Treatment Decisions," that was held on June 20, 2003 in New York City New York City: see New York, city.
New York City
City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. , has been uploaded to the ImpactRx website and is available at http://www.impactrx.com/. ImpactRx was the sole source of data presented at the conference, which was hosted by Timothy M. Anderson, M.D., Senior Vice President and Senior Analyst, Pharmaceuticals, of Prudential Financial.
"It is unique to have a conference that drills down into the analytics in this way," said Dr. Anderson. "In the one-year that Prudential Financial has been utilizing ImpactRx data to augment other sources of data, we have routinely gotten a leg up on our competitors in terms of discerning dis·cern·ing
Exhibiting keen insight and good judgment; perceptive.
dis·cerning·ly adv. specific indicating factors beneath the surface of such major events as new drug launches. This conference gave us the opportunity to share this newfound new·found
Recently discovered: a newfound pastime.
Adj. 1. newfound - newly discovered; "his newfound aggressiveness"; "Hudson pointed his ship down the coast of the newfound sea" source of intelligence with our clients and articulate how the factors tracked in this data are critical to a product's ultimate commercial success."
The keynote presentation, delivered by ImpactRx Co-Founder Terry Overton, Ph.D., provided an overview of the data ImpactRx captures on the efficiency of the industry's sales forces and a narrative on the nature of personal pharmaceutical promotion in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. today. Also presenting from ImpactRx were Gerald J. Gallivan, Co-Founder, Chairman and Chief Executive Officer, Robert Caprara, Vice President, Advanced Analytics and Martin Glogowski, Vice President, Market Research. The presentations delivered by these speakers have also been posted to the ImpactRx website (http://www.impactrx.com/) in addition to the keynote presentation.
"We are very encouraged by the high level of interest our data received from the buy-side analysts attending the Prudential conference," said Mr. Gallivan. "To have ImpactRx data utilized -- and recognized in a public forum -- by one of the most respected securities firms in the world is an invaluable endorsement of our capabilities."
ImpactRx comprehensively collects data on promotion and physician treatment decisions for every pharmaceutical product currently marketed in the United States from its exclusive network of high prescribing physicians. Founded in October 2000, ImpactRx's physician network is the source of an unprecedented intelligence capability for tracking the promotional initiatives of the pharmaceutical industry and measuring their effect on prescribing behavior. Based in Mount Laurel, New Jersey, ImpactRx is a private company with investment financing provided by Mediphase Venture Partners (http://www.mediphaseventure.com/) and Oxford Bioscience Partners (http://www.oxbio.com/).
CONTACT: Patrick Angelastro, Vice President, Marketing & Client Services of ImpactRx, Inc., +1-856-273-0221, ext. 102, firstname.lastname@example.org; or Pete Holmberg (Media), +1-917-322-2164, email@example.com, or Melody A. Carey (Investors), +1-917-322-2571, firstname.lastname@example.org, both of Rx Communications Group, LLC (Logical Link Control) See "LANs" under data link protocol.
LLC - Logical Link Control , for ImpactRx, Inc.
Web site: http://www.impactrx.com/ http://www.mediphaseventure.com/ http://www.oxbio.com/